Empowering Pharma, Food & Sustainability Teams to Meet Global Standards

Batch Release Testing

Batch release testing and Qualified Person (QP) certification are mandatory steps for placing medicinal products on the EU market. Conscio provides a fully GMP-compliant service that ensures your products meet all regulatory requirements efficiently and on time.

Medicinal products imported from non-MRA (Mutual Recognition Agreement) countries must undergo batch re-testing and QP certification before market release. Manufacturers from MRA countries may qualify for exemptions, but full GMP documentation is required. These requirements follow EU GMP Annexes 16 and 21 and Directive 2001/83/EC.

Batch Release Testing

Batch Release Testing & QP Certification

Batch release testing and Qualified Person (QP) certification are mandatory steps for placing medicinal products on the EU market. Conscio provides a fully GMP-compliant service that ensures your products meet all regulatory requirements efficiently and on time.

Medicinal products imported from non-MRA (Mutual Recognition Agreement) countries must undergo batch re-testing and QP certification before market release. Manufacturers from MRA countries may qualify for exemptions, but full GMP documentation is required. These requirements follow EU GMP Annexes 16 and 21 and Directive 2001/83/EC.

With GMP-certified laboratories in Czechia, Slovakia, and Austria, strategically located in the heart of Europe, we offer:

  • Fast, cost-effective access to all EU member states
  • Regulatory expertise at EU and national levels
  • Over 20 years of experience under EU and US FDA oversight

Capabilities:

  • Analytical method implementation, verification, and validation
  • QC testing of clinical and commercial products
  • Physical, chemical, and microbiological testing under cGMP
  • Testing of raw materials, excipients, and APIs
  • QP data review and certification for EU market release
  • Batch release in line with your Marketing Authorisation
  • ICH-compliant and custom stability storage (250 m³ capacity)

We support a wide range of dosage forms, including solids, liquids, injectables, oral films (ODFs), patches, and more.

Method Implementation

Our R&D teams verify and optimise methods before cGMP testing begins, reducing the risk of Out-of-Specification (OOS) results and preventing costly delays. To enhance method suitability, robustness is assessed early using a systematic approach—this includes evaluating parameters such as specificity, accuracy, precision, linearity, detection limits, and robustness, in line with ICH and FDA expectations. Such thorough preparation ensures that analytical methods perform reliably during routine GMP testing and helps safeguard product quality and regulatory compliance.

Additional Services

Let’s Get in Touch

If you have questions about Conscio Group or our range of services, or need
guidance on which solution best fits your needs, feel free to contact us.

How can we support your organization?

Let’s talk. Whether you’re scaling operations or prepping for your next audit, we’ll help you take the next confident step.